Mastering the Mid-face with Revanesse

REVANESSE® causes a stir within the aesthetics industry following its official launch at CCR

A leading global voice in non-surgical aesthetics, Dr Arthur Swift, roused widespread anticipation when he took to the stage to reveal his world-renowned injection techniques at CCR in London on October 14 and 15.

The aesthetics heavyweight spilled his secrets in a symposium on the OMGEE Curve: Mastering of the Mid-face with REVANESSE®. A play on the Ogee Curve, the name given to the double S-shaped curvature along the cheeks that gives the face contour and dimension, the symposium uncovered Dr Swift’s secrets to creating mid-face masterpieces, unveiling the injection techniques he uses to counteract the downward protection that occurs with age.

Citing the amazing rheology of REVANESSE®, Dr Swift explained how he uses SHAPE™ deep in the periosteal plane to project and lift, followed by CONTOUR™ deftly layered with a cannula to create the soft, S-shaped curves he’s famous for. He cast a spotlight on two of his most illustrious techniques, united in the idea that a systematic approach to cheek enhancement means using less product to achieve better results. The doorstep technique Using the tacky texture of REVANESSE® CONTOUR™, Dr Swift performs what he calls the ‘Doorstop Technique’. Pulling the skin of the jawline back towards the upper ear, he injects a small bolus of the product to act as a doorstop, preventing the retaining ligaments from folding forward. While he proceeds to inject the other side, the patient is tasked with holding the face in place with a cold compress.

The double scoop Likening the product to a scoop of ice cream, Dr Swift layers two boluses on top of one another to project the cheek upwards. Using REVANESSE® SHAPE™, he injects a small bolus down onto the bone before lifting the skin up vertically and injecting a second bolus directly on top. The two balls of product sit on top of each other and push the mid-face up, as opposed to projecting it outwards.

The Swift seal of approval One of only five companies to receive FDA approval, REVANESSE® has already become a big player in the US and Canada,1 where it has revolutionised the aesthetics market with its unique formula, commitment to high-quality ingredients, and innovative manufacturing technique. The state-of-the-art dermal filler has spherical particles which give it its key selling points of safety and performance. The gel’s smooth integration can be linked to their particle shape and low levels of modification, which can reduce immune responses and inflammation.2,3 The spherical shape is designed to be accepted by the body and provide smooth, beautiful results that perform throughout the lifecycle of the skin.

Have you tried REVANESSE® in clinic yet?

Try one of each product Kiss, Ultra, Contour & Shape for a special offer price of £532. At just £66 per 1.2ml syringe, this equates to £55/1ml… that’s more fill for your ML!

Redeem with code: JanAJ22

It’s simple, type the code into the search bar and your basket will load with the special offer! Offer valid for a limited time only at Healthxchange Smooth Spheres, Less Inflammation, More Volume.

This advertorial was written and supplied by

For more information, please contact info@prollenium.co.uk

@prolleniumuk Prollenium UK

REFERENCES

1. FDA Premarket Approval (PMA) Database (P040024/S072).

Approval OrderStatement for Restylane® Silk™, 2014. Restylane® is a registered trademark of Nestlé Skin Health SA. 2. Edsman K, Nord LI, Ohrlund A, et al. Gel properties of hyaluronic acid dermal fillers. Dermatol Surg. 2012;38:1170–1179. 3. Laeschke K. Biocompatibility of microparticles into soft tissue fillers. Semin Cutan Med Surg. 2004 Dec;23(4):214-7. doi: 10.1016/j.sder.2004.09.005.